Artemis Gavriil

Artemis Gavriil has a diverse work experience in the field of research. They started their career at Democritus University of Thrace, working as an Undergraduate Researcher in the Laboratory of Developmental Biology & Molecular Neurobiology and later in the Laboratory of Experimental Surgery & Surgical Research. During this time, they gained experience in various laboratory techniques and animal handling.

Artemis then moved on to pursue their postgraduate studies at University College London (UCL), where they worked as a Postgraduate Researcher in the UCL Cancer Institute. Here, their research focused on engineering Chimeric Antigen Receptors (CARs) for the treatment of AML and the avoidance of on-target off-tumor toxicities.

Following their postgraduate studies, Artemis joined King's College London as a PhD student. The specific details of their research during this time are not provided.

From 2017 to 2021, Artemis worked as a Postdoctoral Research Fellow at UCL in Prof. John Anderson's research group in the UCL Institute of Child Health. Their research projects involved the development of various CAR and engineered TCR approaches for the treatment of childhood cancers.

Most recently, in 2021, Artemis joined Quell Therapeutics as a Scientist II in the Discovery & New Technologies department. No specific details about their role are provided.

Overall, Artemis Gavriil has gained significant research experience in the fields of cancer treatment and cell engineering, working at prestigious institutions such as UCL and King's College London.

Artemis Gavriil has a high school degree from The Ethnarchis Makarios III, 1st Lyceum of Paphos, which they obtained from 2005 to 2008. Later, they pursued a Bachelor's degree in the School of Molecular Biology and Genetics from Democritus University of Thrace, attending from 2008 to 2013. Artemis then pursued a Master of Science (MS) degree in Cancer from UCL, from 2013 to 2014. Artemis Gavriil further expanded their education by completing a Doctor of Philosophy (PhD) degree in Oncology and Cancer Biology from King's College London, from 2014 to 2017.